Synergy CHC Corp. logo

Synergy CHC Corp.

SNYR

NASDAQHealthcareMedical - Distribution

Previous close

$0.1009

−$0.0154 · -13.24%

Aug 21, 4:00 PM ET

SNYR company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

37

Expensive

Momentum

17

Strong Down

Sentiment

40

Bearish

Risk resilience

32

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Synergy CHC Corp. operates as a distributor of diverse consumer health, beauty, and lifestyle merchandise across the United States, Canada, and the United Kingdom. The company's brand portfolio features FOCUSfactor, specializing in nutritional supplements aimed at enhancing brain function. It also offers the Flat Tummy line, which includes a range of wellness and fashion items such as specialty teas, meal replacement shakes, lollipops, dietary aids, apparel, and exercise accessories. Furthermore, under the Hand MD brand, Synergy CHC Corp. provides anti-aging skincare products, encompassing serums and creams designed for exfoliation, skin repair, and rehydration, as well as hand hygiene products like soaps and sanitizers. These goods are made available to consumers through conventional retail partners and significant television advertising campaigns. The company's skincare range, in particular, is also sold directly via online platforms. Founded in 2010, the firm was originally named Synergy Strips Corp. and rebranded to Synergy CHC Corp. in August 2015. Its primary business operations are based in Westbrook, Maine.

Industry
Medical - Distribution
Sector
Healthcare
Headquarters
US
CEO
Jack Ross
Listed since
Mar 17, 2014
Employees
28

Market position

Day range

Current $0.1009

52-week range

Current $0.1009

Open
$0.1095
Previous close
$0.1163
Volume
2.7M
0.55× average
Average volume
4.9M
Average daily volume
Market cap
1.05M USD
Beta
0.74
Market reference 1
50-day average
$0.1791
-43.67% below average
200-day average
$1.0157
-90.07% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
42.28M USD
P/E (TTM)
-0.06×
P/B (TTM)
-0.04×
P/S (TTM)
0.04×
EV / EBITDA
-6.85×
Earnings yield
-68.24%
Free cash flow yield
-14.29%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
65.13%
Operating margin
-15.57%
Net margin
-56.98%
Return on equity
53.36%
Return on assets
-121.42%
Return on invested capital
-48.77%

Financial health

Debt / equity
-1.09×
Current ratio
1.22×

Earnings

EPS beat rate
29%
2 beats, 3 misses, 2 met estimates
Average EPS surprise
-571.62%
7 comparable reports
Latest EPS result
-0.23
Estimate 0.03 · Miss by 866.67%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.210.02-0.16-0.35Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25MetQ2 '26MissQ2 '26MissQ3 '26EstimateQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual 0.01, estimate 0.1, surprise -90.00%, Miss. Q2 2025, reported May 15, 2025: actual 0.1, estimate 0.07, surprise +42.86%, Beat. Q3 2025, reported Aug 14, 2025: actual 0.17, estimate 0.08, surprise +112.50%, Beat. Q4 2025, reported Nov 13, 2025: actual 0.01, estimate 0.01, surprise 0.00%, Met estimate. Q2 2026, reported Apr 1, 2026: actual -0.31, estimate 0.01, surprise -3200.00%, Miss. Q2 2026, reported May 14, 2026: actual -0.23, estimate 0.03, surprise -866.67%, Miss. Q3 2026, reported Aug 27, 2026: actual —, estimate -0.01, surprise —, Comparison unavailable. Q4 2026, reported Nov 12, 2026: actual —, estimate -0.01, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates11.34M9.24M7.15M5.06MQ1 '25BeatQ2 '25MissQ3 '25MissQ4 '25MissQ2 '26MissQ2 '26MissQ3 '26EstimateQ4 '26Estimate
Q1 2025, reported Mar 31, 2025: actual 10.3M USD, estimate 9.03M USD, surprise +14.13%, Beat. Q2 2025, reported May 15, 2025: actual 8.17M USD, estimate 10.8M USD, surprise -24.35%, Miss. Q3 2025, reported Aug 14, 2025: actual 8.1M USD, estimate 10.8M USD, surprise -25.00%, Miss. Q4 2025, reported Nov 13, 2025: actual 8.01M USD, estimate 10.9M USD, surprise -26.51%, Miss. Q2 2026, reported Apr 1, 2026: actual 6.07M USD, estimate 10.83M USD, surprise -43.95%, Miss. Q2 2026, reported May 14, 2026: actual 5.49M USD, estimate 8.33M USD, surprise -34.09%, Miss. Q3 2026, reported Aug 27, 2026: actual —, estimate 8M USD, surprise —, Comparison unavailable. Q4 2026, reported Nov 12, 2026: actual —, estimate 8M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$7.50

7333.10% upside
Past 12 months12-month forecastHigh $10.00Average $7.50Low $5.00

Recent analyst actions

2 institutions
Roth CapitalmaintainBuy

SNYR news

SNYR peers

ETFs holding SNYR

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research SNYR

research.disclaimer